PFIZER INC — Director's Dealing 2022

May 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2022-05-11

Reporting Person: Dolsten Mikael (President R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-11	Common Stock	S	200.0000	$49.3600	Disposed	397044.0000	Direct
2022-05-11	Common Stock	S	2358.0000	$49.3400	Disposed	394686.0000	Direct
2022-05-11	Common Stock	S	2891.0000	$49.3500	Disposed	391795.0000	Direct
2022-05-11	Common Stock	S	7876.0000	$49.3300	Disposed	383919.0000	Direct
2022-05-11	Common Stock	S	18562.0000	$49.3200	Disposed	365357.0000	Direct
2022-05-11	Common Stock	S	32015.0000	$49.3100	Disposed	333342.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-11	Phantom Stock Units SSP	$	I	15167.0000	Acquired		Common Stock (15167.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1817.0000	Indirect

Footnotes

F1: Each unit represents one phantom share of common stock.

F2: This transaction constitutes an intra-plan transfer into the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan.

F3: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.